BriaCell Partners with Waisman Biomanufacturing to Manufacture and Supply Prostate Cancer Immunotherapy Pharmaceutical Investing
BioHarvest Sciences Inc. Reports Strong Q2 2022 Results with Major Achievements on All Fronts Life Science Investing
Awakn Life Sciences Receives UK State Funding to Identify Optimal Pathway to Market in UK & US for Its Lead Clinical Development Program - Ketamine-Assisted Therapy for Alcohol Use Disorder Company News
BioHarvest Sciences Inc. Announces Appointment of Gavriel Lambert to the Board of Advisors Company News
BriaCell Enters Research Agreement to Identify Novel Targets for Cancer Treatment Pharmaceutical Investing
The Gummy Project Announces Another Milestone with Entry into Canadian Retail Market Life Science Investing
Mindset Pharma Announces Development of Novel, Optimized, Intranasal Formulation Life Science Investing
